AIMS/HYPOTHESIS: Beta cells situated in the islet of Langerhans respond more vigorously to glucose than do dissociated beta cells. Mechanisms for this discrepancy were studied by comparing insulin-producing MIN6 cells aggregated into pseudoislets with MIN6 monolayer cells and mouse and human islets. METHODS: MIN6 monolayers, pseudoislets and mouse and human islets were exposed to glucose, α-ketoisocaproic acid (KIC), pyruvate, KIC plus glutamine and the phosphatidylinositol 3-kinase (PI3K) inhibitors LY294002 or wortmannin. Insulin secretion (ELISA), cytoplasmic Ca(2+) concentration ([Ca(2+)]c; microfluorometry), glucose oxidation (radiolabelling), the expression of genes involved in mitochondrial metabolism (PCR) and the phosphorylation of insulin receptor signalling proteins (western blotting) were measured. RESULTS: Insulin secretory responses to glucose, pyruvate, KIC and glutamine were higher in pseudoislets than monolayers and comparable to those of human islets. Glucose oxidation and genes for mitochondrial metabolism were upregulated in pseudoislets compared with single cells and monolayers, respectively. Phosphorylation at the inhibitory S636/639 site of IRS-1 was significantly higher in monolayers and dispersed human and mouse cells than pseudoislets and intact human and mouse islets. PI3K inhibition only slightly attenuated glucose-stimulated insulin secretion from monolayers, but substantially reduced that from pseudoislets and human and mouse islets without suppressing the glucose-induced [Ca(2+)]c response. CONCLUSIONS/ INTERPRETATION: We propose that islet architecture is critical for proper beta cell mitochondrial metabolism and IRS-1 signalling, and that PI3K regulates insulin secretion at a step distal to the elevation of [Ca(2+)]c.
AIMS/HYPOTHESIS: Beta cells situated in the islet of Langerhans respond more vigorously to glucose than do dissociated beta cells. Mechanisms for this discrepancy were studied by comparing insulin-producing MIN6 cells aggregated into pseudoislets with MIN6 monolayer cells and mouse and human islets. METHODS: MIN6 monolayers, pseudoislets and mouse and human islets were exposed to glucose, α-ketoisocaproic acid (KIC), pyruvate, KIC plus glutamine and the phosphatidylinositol 3-kinase (PI3K) inhibitors LY294002 or wortmannin. Insulin secretion (ELISA), cytoplasmic Ca(2+) concentration ([Ca(2+)]c; microfluorometry), glucose oxidation (radiolabelling), the expression of genes involved in mitochondrial metabolism (PCR) and the phosphorylation of insulin receptor signalling proteins (western blotting) were measured. RESULTS:Insulin secretory responses to glucose, pyruvate, KIC and glutamine were higher in pseudoislets than monolayers and comparable to those of human islets. Glucose oxidation and genes for mitochondrial metabolism were upregulated in pseudoislets compared with single cells and monolayers, respectively. Phosphorylation at the inhibitory S636/639 site of IRS-1 was significantly higher in monolayers and dispersed human and mouse cells than pseudoislets and intact human and mouse islets. PI3K inhibition only slightly attenuated glucose-stimulated insulin secretion from monolayers, but substantially reduced that from pseudoislets and human and mouse islets without suppressing the glucose-induced [Ca(2+)]c response. CONCLUSIONS/ INTERPRETATION: We propose that islet architecture is critical for proper beta cell mitochondrial metabolism and IRS-1 signalling, and that PI3K regulates insulin secretion at a step distal to the elevation of [Ca(2+)]c.
Authors: Emilyn U Alejandro; Gareth E Lim; Arya E Mehran; Xiaoke Hu; Farnaz Taghizadeh; Dmytro Pelipeychenko; Manuela Baccarini; James D Johnson Journal: FASEB J Date: 2011-08-04 Impact factor: 5.191
Authors: N Sekine; V Cirulli; R Regazzi; L J Brown; E Gine; J Tamarit-Rodriguez; M Girotti; S Marie; M J MacDonald; C B Wollheim Journal: J Biol Chem Date: 1994-02-18 Impact factor: 5.157
Authors: Anna Munder; Liron L Israel; Shirin Kahremany; Rina Ben-Shabat-Binyamini; Charles Zhang; Michal Kolitz-Domb; Olga Viskind; Anna Levine; Hanoch Senderowitz; Steven Chessler; Jean-Paul Lellouche; Arie Gruzman Journal: ACS Appl Mater Interfaces Date: 2017-01-03 Impact factor: 9.229
Authors: Thomas H Hraha; Abigail B Bernard; Linda M Nguyen; Kristi S Anseth; Richard K P Benninger Journal: Biophys J Date: 2014-01-07 Impact factor: 4.033
Authors: Poonam R Sharma; Aaron J Mackey; Eden A Dejene; James W Ramadan; Carl D Langefeld; Nicholette D Palmer; Kent D Taylor; Lynne E Wagenknecht; Richard M Watanabe; Stephen S Rich; Craig S Nunemaker Journal: Endocrinology Date: 2015-05-27 Impact factor: 4.736
Authors: Jelena Kolic; Jocelyn E Manning Fox; Oleg G Chepurny; Aliya F Spigelman; Mourad Ferdaoussi; Frank Schwede; George G Holz; Patrick E MacDonald Journal: Mol Metab Date: 2016-05-11 Impact factor: 7.422
Authors: E Carchia; I Porreca; P J Almeida; F D'Angelo; D Cuomo; M Ceccarelli; M De Felice; M Mallardo; C Ambrosino Journal: Cell Death Dis Date: 2015-10-29 Impact factor: 8.469